Brief: AnaptysBio Q3 Net Income USD 15.113 Million
04/11/2025 21:15
Nov 04 (Reuters) - AnaptysBio Q3 collaboration revenue USD 76.32 million. Q3 operating expenses USD 41.616 million Q3 income from operations USD 34.704 million
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties